15358-23-3 Usage
Description
(5α,7β)-4,5-epoxy-17-methyl-3,6-dimethoxy-7β-acetyl-6,14-ethenomorphinan is a morphinan alkaloid with a unique chemical structure, featuring a 4,5-epoxy ring, a 17-methyl group, two methoxy groups at positions 3 and 6, an acetyl group at position 7β, and a double bond at positions 6 and 14. (5α,7β)-4,5-epoxy-17-methyl-3,6-dimethoxy-7β-acetyl-6,14-ethenomorphinan may possess potential pharmacological and medicinal properties.
Uses
Used in Pharmaceutical Industry:
(5α,7β)-4,5-epoxy-17-methyl-3,6-dimethoxy-7β-acetyl-6,14-ethenomorphinan is used as a potential candidate for the development of new medications due to its possible analgesic, sedative, and antitussive effects. Its unique structure and properties make it a promising compound for pain management and cough suppression therapies.
Further research is required to fully understand the biological activities and potential therapeutic applications of (5α,7β)-4,5-epoxy-17-methyl-3,6-dimethoxy-7β-acetyl-6,14-ethenomorphinan, as its current understanding is limited.
Check Digit Verification of cas no
The CAS Registry Mumber 15358-23-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,3,5 and 8 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 15358-23:
(7*1)+(6*5)+(5*3)+(4*5)+(3*8)+(2*2)+(1*3)=103
103 % 10 = 3
So 15358-23-3 is a valid CAS Registry Number.
15358-23-3Relevant articles and documents
Processes for the synthesis of opiates alkaloids with reduced impurity formation
-
Page/Page column 7, (2010/04/25)
The invention provides processes for the production of opiate alkaloids. In particular, the present invention provides processes for the formation of opiate alkaloids that minimizes the formation of impurities.
Synthesis of N-substituted 7β-diprenorphine derivatives
Marton,Miklos,Hosztafi,Makleit
, p. 829 - 848 (2007/10/02)
The separation of thevinone (2a) and β-thevinone (2b), as well as that of dihydrothevinone (3a) and β-dihydrothevinone (3b) was accomplished. By the application of various procedures numerous new N-substituted Diprenorphine analogues (8a-f) with 7R absolute configuration were synthesized. Detailed pharmacological investigation of the prepared compounds may contribute to a better understanding of the structure-activity relationship of morphine alkaloids.
